Literature DB >> 22761415

TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.

Soo-Hyun Yoon1, Yong Deok Lee, Jeongim Ha, Youngkyun Lee, Hong-Hee Kim.   

Abstract

Triggering receptor expressed on myeloid cells (TREM)-like transcript-1 (TLT-1) is an immunoreceptor tyrosine-based inhibitory motif (ITIM)-baring TREM family protein. In this study, we identified an alternative transcript form of TLT-1, namely TLT-1s, which has very short extracellular immunoglobulin domain consisting of only 202 amino acids. TLT-1s was mainly expressed in macrophages and osteoclast precursor cells. Upon receptor activator of nuclear factor-κB ligand stimulation, TLT-1s mRNA and protein levels were gradually decreased in BMMs. We also showed the TLT-1s is localized to the cytoplasmic membrane in osteoclast precursor cells. TLT-1s silencing strongly enhanced the formation and resorption activity of osteoclast. In addition, forced expression of TLT-1s showed reduced formation of osteoclast. Because ITIM-baring proteins inhibit immunoreceptor tyrosine-based activation motif (ITAM)-mediated receptor signaling, we tested whether TLT-1s physically interacted with TREM-2, the ITAM-associated co-stimulatory receptor essential for osteoclast differentiation. We showed that TLT-1s is associated with TREM-2 in osteoclast precursor cells. TLT-1s is also associated with tyrosine Src homology 2 domain-containing phosphatase-1 and SH2 domain-containing inositol phosphatase-1 and recruited them to the TREM2-ITAM signaling complex. In addition, knockdown of TLT-1s markedly elevated the intracellular calcium concentration and oscillation in osteoclast precursor cells. In addition, calcium-mediated induction of nuclear factor of activated T cells was also increased by TLT-1s silencing. Furthermore, TREM-2-mediated Akt activation and proliferation of osteoclast precursor cells were also enhanced in TLT-1s silenced cells. In this paper, we found the noble ITIM-baring inhibitory membrane protein; TLT-1s, which regulates ITAM-mediated signaling on osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761415      PMCID: PMC3436187          DOI: 10.1074/jbc.M112.351239

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 2.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 3.  TREMs in the immune system and beyond.

Authors:  Marco Colonna
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

4.  Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17.

Authors:  Dong-Hui Chung; William E Seaman; Michael R Daws
Journal:  Eur J Immunol       Date:  2002-01       Impact factor: 5.532

5.  A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.

Authors:  Joshua R Bleharski; Viviane Kiessler; Cecilia Buonsanti; Peter A Sieling; Steffen Stenger; Marco Colonna; Robert L Modlin
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

Authors:  Takako Koga; Masanori Inui; Kazuya Inoue; Sunhwa Kim; Ayako Suematsu; Eiji Kobayashi; Toshio Iwata; Hiroshi Ohnishi; Takashi Matozaki; Tatsuhiko Kodama; Tadatsugu Taniguchi; Hiroshi Takayanagi; Toshiyuki Takai
Journal:  Nature       Date:  2004-04-15       Impact factor: 49.962

7.  The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

Authors:  Attila Mócsai; Mary Beth Humphrey; Jessica A G Van Ziffle; Yongmei Hu; Andrew Burghardt; Steven C Spusta; Sharmila Majumdar; Lewis L Lanier; Clifford A Lowell; Mary C Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

8.  Initial characterization of TREM-like transcript (TLT)-1: a putative inhibitory receptor within the TREM cluster.

Authors:  A Valance Washington; Laura Quigley; Daniel W McVicar
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

9.  Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.

Authors:  Timothy J Bauler; Nobuhiro Kamiya; Philip E Lapinski; Eric Langewisch; Yuji Mishina; John E Wilkinson; Gen-Sheng Feng; Philip D King
Journal:  Dis Model Mech       Date:  2010-11-10       Impact factor: 5.758

10.  Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.

Authors:  Alexander D Barrow; Emmanuelle Astoul; Andres Floto; Gary Brooke; Ingrid A M Relou; Nicola S Jennings; Kenneth G C Smith; Willem Ouwehand; Richard W Farndale; Denis R Alexander; John Trowsdale
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  11 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

Review 2.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

Review 3.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

4.  The Characterization of Monoclonal Antibodies to Mouse TLT-1 Suggests That TLT-1 Plays a Role in Wound Healing.

Authors:  Barbara Manfredi; Jessica Morales-Ortíz; Lymarie M Díaz-Díaz; Liz Hernandez-Matias; Delmaliz Barreto-Vázquez; Javier Menéndez-Pérez; J Alejandro Rodríguez-Cordero; Juan C Villalobos-Santos; Edgardo Santiago-Rivera; Adriana Rivera-Dompenciel; Eunice L Lozada-Delgado; Madhavi Kuchibhotla; Kelvin Carrasquillo-Carrión; Abiel Roche-Lima; A Valance Washington
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2018-04

Review 5.  The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis.

Authors:  Marco Genua; Sergio Rutella; Carmen Correale; Silvio Danese
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

6.  Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms.

Authors:  Daniel L Kober; Jennifer M Alexander-Brett; Celeste M Karch; Carlos Cruchaga; Marco Colonna; Michael J Holtzman; Thomas J Brett
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

Review 7.  The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1).

Authors:  Siobhan Branfield; A Valance Washington
Journal:  Platelets       Date:  2021-02-09       Impact factor: 4.236

Review 8.  Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease.

Authors:  Todd E Golde; Wolfgang J Streit; Paramita Chakrabarty
Journal:  Alzheimers Res Ther       Date:  2013-05-21       Impact factor: 6.982

Review 9.  TREM2 in Neurodegenerative Diseases.

Authors:  Taylor R Jay; Victoria E von Saucken; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2017-08-02       Impact factor: 14.195

10.  Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model.

Authors:  Jessica Morales-Ortíz; Victoria Deal; Fiorella Reyes; Gerónimo Maldonado-Martínez; Nahomy Ledesma; Franklin Staback; Cheyanne Croft; Amanda Pacheco; Humberto Ortiz-Zuazaga; C Christian Yost; Jesse W Rowley; Bismark Madera; Alex St John; Junmei Chen; Jose Lopez; Matthew T Rondina; Robert Hunter; Angelia Gibson; A Valance Washington
Journal:  Blood       Date:  2018-10-03       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.